Cite
HARVARD Citation
Holekamp, N. et al. (2020). Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data. Journal of medical economics. pp. 287-296. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Holekamp, N. et al. (2020). Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data. Journal of medical economics. pp. 287-296. [Online].